MedPointe Sues Generics Maker Over Allergy Spray

Law360, New York (August 23, 2007, 12:00 AM EDT) -- MedPointe Healthcare Inc. on Wednesday filed a patent infringement suit against Cobalt Pharmaceuticals Inc. in an attempt to stop the Canadian drug company from making a generic version of its anti-allergy medication.

The suit centers on U.S. Patent Number 5,164,194, issued in November 1992 and entitled “aAelastine containing medicaments.” MedPointe has owned the patent, which is slated to expire in 2011, since August 2002.

MedPointe accuses Cobalt of submitting an Abbreviated New Drug Application to the U.S. Food and Drug Administration in 2005 for a .125...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.